Imatinib mesylate can induce molecular remissions in chronic myeloid leukemia

被引：0
|
作者：
Lawler, M
Gately, K
Ryan, J
Carroll, P
Howard, J
Stallings, R
Conneally, E
McCann, S
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [31] Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia
    Peggs, K
    Mackinnon, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11): : 1048 - 1050
  • [32] Lichen planus in a patient with chronic myeloid leukemia taking imatinib mesylate
    Carneiro de Castro, Carlos Gustavo
    dos Santos, Aline Sarkis
    Meotti, Carolina Degen
    Gama, Carolina Mendonca
    Silveira, Luisa Kelmer
    Serafini, Natalia Battisti
    Pereira, Raquel Noschang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB205 - AB205
  • [33] Cytogenetic responses in chronic myeloid leukemia patients treated with imatinib mesylate
    Babameto-Laku, A.
    Mokin, V.
    Cikuli, M.
    Xhumari, P.
    CHROMOSOME RESEARCH, 2005, 13 : 158 - 158
  • [34] Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
    Hu, Zheng
    Pan, Xiao-Fen
    Wu, Fu-Qun
    Ma, Li-Yuan
    Liu, Da-Peng
    Liu, Ying
    Feng, Ting-Ting
    Meng, Fan-Yi
    Liu, Xiao-Li
    Jiang, Qian-Li
    Chen, Xiao-Qin
    Liu, Jing-Lei
    Liu, Ping
    Chen, Zhu
    Chen, Sai-Juan
    Zhou, Guang-Biao
    PLOS ONE, 2009, 4 (07):
  • [35] Treatment modalities in hematology: Imatinib mesylate as therapy for chronic myeloid leukemia
    A. Gratwohl
    International Journal of Hematology, 2002, 76 : 149 - 149
  • [36] Treatment modalities in hematology: Imatinib mesylate as therapy for chronic myeloid leukemia
    Gratwohl, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 149 - 149
  • [37] Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate
    Zonder J.A.
    Schiffer C.A.
    Current Hematologic Malignancy Reports, 2006, 1 (3) : 141 - 151
  • [38] Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy
    Goldberg, SL
    Madan, RA
    Rowley, SD
    Pecora, AL
    Hsu, JW
    Tantravahi, R
    BLOOD, 2003, 101 (02) : 781 - 781
  • [39] Imatinib mesylate, a new drug for chronic myeloid leukemia in pediatric patients
    Thavaraj, Vasantha
    Seth, Rachna
    WORLD JOURNAL OF PEDIATRICS, 2007, 3 (02) : 110 - 114
  • [40] Nutritional Status of Patients with Chronic Myeloid Leukemia Treated with Imatinib Mesylate
    Jose Castillo-Martinez, Maria
    Juventina Tuna-Aguilar, Elena
    del Pilar Milke-Garcia, Maria
    Camacho Zamora, Anais
    Villegas Cervantes, Viviana
    Castillo-Martinez, Lilia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (09): : 3211 - 3216
12345